Assessing the Effectiveness of Levosalbutamol Alone Versus Levosalbutamol/Ipratropium Bromide Combination nebulisation in Managing Wheezing in Children Under Five Years of age
Not Applicable
Recruiting
- Conditions
- Health Condition 1: J988- Other specified respiratory disorders
- Registration Number
- CTRI/2024/04/066112
- Lead Sponsor
- Dr Aravind Siva SR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age 29 days to 5 days of any gender
2.Children with acute episode of wheeze caused by asthma,WALRI,Lower repiratory tract infections including,bronchiolitis and bronchopneumonia
3.Presence of moderate or severe respiratory distress based on CAS score.
4.Parents giving consent for the study.
Exclusion Criteria
1.Children above 5 years of age
2.Wheeze casued by airway obstruction due to anatomical causeslike foreign body,tumours,airway malformations,vascular anomalies
3.Mild repiratory distress based on CAS
4.Parents not willing and give consent for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The childs distress will be assessed using Clinical Asthma Severity Score as Mild,Moderate and SevereTimepoint: Nebulisations will be given at 0 20 and 40 mins and will be reassesed at 30 and 60 mins after nebulisations.
- Secondary Outcome Measures
Name Time Method To compare the sideeffects of levosalbutamol & levosalbuatamol/ipratropium bromide nebulisationsTimepoint: Nebulisation will be given at 0,20 & 40 minutes & the child will be assesed at 3Omins & 60 mins after nebulisation by Clinical Asthma Severity Score